Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
204 USD | +1.01% | +7.08% | -21.16% |
02:57pm | Goldman Sachs Adjusts Biogen Price Target to $340 From $393 | MT |
02:39pm | Canaccord Genuity Adjusts Price Target on Biogen to $308 From $305 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.16% | 29.36B | |
-2.86% | 87.31B | |
+3.95% | 40.86B | |
+57.67% | 24.49B | |
-13.89% | 17.31B | |
-18.03% | 11.62B | |
-13.96% | 11.31B | |
-44.23% | 11.26B | |
+7.49% | 8.31B | |
-9.82% | 7.9B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Biogen : JPMorgan Adjusts Biogen PT to $435 From $269, Maintains Neutral Rating